EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

Genetically engineered hypoimmunogenic iPSCs: Strategies and considerations for clinical applications

Jason K M Choi, Akitsu Hotta

Regenerative Therapy · 2026-12 · 33 · 101172

DOI: 10.1016/j.reth.2026.101172 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Regenerative Therapy, 2026-12. Verfasst von Jason K M Choi und 1 weiteren Autor:innen. Beteiligte Einrichtung: Center for iPS Cell Research and Application (CiRA), Kyoto University, Kyoto, Japan. Die Arbeit nennt 129 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Japan Society for the Promotion of Science, Japan Science and Technology Agency, Japan Agency for Medical Research and Development.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

Allogeneic cell therapyGenome editingHypoimmunogenic cell lineQuality controliPS cells

Autor:innen und Institutionen

  • Center for iPS Cell Research and Application (CiRA), Kyoto University, Kyoto, Japan.

Förderung

  • Japan Society for the Promotion of Science
  • Japan Science and Technology Agency
  • Japan Agency for Medical Research and Development

Zitieren

APA

Choi, J. K. M., & Hotta, A. (2026). Genetically engineered hypoimmunogenic iPSCs: Strategies and considerations for clinical applications. Regenerative Therapy, 33, 101172. https://doi.org/10.1016/j.reth.2026.101172

Vancouver

Choi JKM, Hotta A. Genetically engineered hypoimmunogenic iPSCs: Strategies and considerations for clinical applications. Regenerative Therapy. 2026;33:101172. doi:10.1016/j.reth.2026.101172

BibTeX
@article{Choi2026,
  author = {Choi, Jason K M and Hotta, Akitsu},
  title = {Genetically engineered hypoimmunogenic iPSCs: Strategies and considerations for clinical applications},
  journal = {Regenerative Therapy},
  year = {2026},
  volume = {33},
  pages = {101172},
  doi = {10.1016/j.reth.2026.101172}
}
Kostenlos starten →